The headline numbers for Exelixis (EXEL) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street ...

Exelixis posts strong Q3 results with earnings and revenue beats, boosted by Cabometyx sales, and narrows 2025 guidance.

From AI-driven personalisation to seamless omnichannel integrations, eCommerce Expo 2025 proved that innovation in commerce ...

Detailed price information for Simplify Growth Equity Plus Downside Convex ETF (QQD-Q) from The Globe and Mail including charting and trades.